EHRs

From inking EHR contracts to making an investment into clinical research company Elligo Health, here are seven updates on Cerner's operations, software products and partnerships reported by Becker's Hospital Review in September. 

David Feinberg, MD, former head of Google Health, officially takes the reins as Cerner's CEO Oct. 1. In a recent op-ed shared on LinkedIn, he shared the motivation behind taking on the new role: the opportunity to use tech to…

David Walker, MD, the director of Veterans Affairs medical care for nearly all of Georgia, has launched an investigation into the Atlanta VA Medical Center after 10 pallets of mail were left in the basement for 10 months, according to…

From its new partnership with Walmart Health to rolling out digital vaccine record technology for millions of patients, here are seven updates on Epic's operations, software products and partnerships reported by Becker's Hospital Review in September.  

Thirty-eight percent of Americans accessed a patient portal in 2020, according to a report from the Office of the National Coordinator for Health IT.

Walmart Health will use Epic's EHR to engage with patients, payers and healthcare providers, the company said Sept. 27.

Congressional investigators allege three business executives used their connections with former President Donald Trump to influence Department of Veterans Affairs policies, including planning to sell veterans' medical records to turn a profit, according to a Sept. 27 ProPublica report.

Health IT companies that fail to comply with federal information-blocking prohibitions this year could be penalized as much as $1 million per violation, according to a Sept. 27 Bloomberg Law report.

Epic has rolled out technology that serves as a digital vaccination verification by binding a person's identity with their vaccination or lab results and displaying it via QR codes on a smartphone, Wisconsin State Journal reported Sept. 27. 

Elligo Health Research, a healthcare research company that uses EHRs to connect patients to clinical research, has raised $135 million in a series E funding round.